Delivery Order DACA8700D0047-0012

This is a federal contract awarded by the Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense to the Ministry of Defence, doing business as DSTL, a government entity of the United Kingdom. The contract is for the development of a Marburg virus model, with a potential value of $8,062,340.07. The contract is a Definitive Contract with a Cost Plus Fixed Fee pricing type and has an April 30, 2020 completion date. The work supports U.S. defense and homeland...

This is a cost-plus-fixed-fee delivery order contract awarded by the Defense Threat Reduction Agency (DTRA) to the Ministry of Defence, doing business as the Defence Science and Technology Laboratory (DSTL), a United Kingdom government entity. The contract, valued at $4,226,739.50, supports the "BASE PERIOD - AD92" requirement and has an ultimate completion date of June 26, 2021. The contract is not designated as a set-aside. The award is part of a larger Indefinite Delivery Contract...

This is a definitive cost-plus-fixed-fee contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Porton Biopharma Limited, a foreign-owned for-profit organization, with a ceiling value of $12,323,733.00. The contract was awarded as a result of a novation, with the prior contract HHSN272201200032C with Public Health England now being HHSN272201600045C with Porton Biopharma Limited as the successor-in-interest contractor. The contract does not...

This is a $181,727 delivery order contract awarded by the Defense Threat Reduction Agency (DTRA) to the Ministry of Defence, doing business as DSTL, a U.K. government entity. The contract is for the "Counter-WMD Analysis Cell (C-WAC)" and does not have a set-aside designation. The contract type is cost-plus-fixed-fee. The period of performance runs through December 30, 2017. The Ministry of Defence has previously been awarded prime contracts by DTRA and the Department of Homeland...

This is a federal contract award to the Ministry of Defence (doing business as DSTL), a government entity in the United Kingdom, by the Defense Threat Reduction Agency (DTRA). The $824,565 cost-plus-fixed-fee contract supports chemical agent system testing. The work, which is not set aside, involves research and development services focused on countering chemical, biological, radiological, and nuclear threats. This includes developing medical countermeasures, diagnostic tools, conducting...

This is a federal contract award to the Ministry of Defence (MOD), doing business as the Defence Science and Technology Laboratory (DSTL), a United Kingdom government entity. The $4,636,158.00 cost-plus-fixed-fee contract was awarded by the Defense Threat Reduction Agency (DTRA) with a period of performance ending on September 30, 2022. The contract has no set-aside designation. DSTL is an experienced provider of advanced research and development services to U.S. federal agencies, with a focus...

This is a Cost Plus Fixed Fee contract valued at $1,289,074.82 awarded by the Defense Advanced Research Projects Agency (DARPA) to the Ministry of Defence (MOD) of the United Kingdom, doing business as the Defense Science and Technology Laboratory (DSTL). The contract is for the "Interfering and Co-Evolving Prevention and Therapy (INTERCEPT) PROGRAM", which involves research and development services focused on countering chemical, biological, radiological, and nuclear threats. The work...

This $569,784 firm-fixed-price federal contract was awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to the University of Oxford, a non-profit educational institution located in the United Kingdom. The contract is for clinical sample gonorrhea sequencing services to combat antibiotic resistance. No set-aside designation was utilized. The University of Oxford has extensive experience as a prime and subcontractor on federal research and healthcare...

This is a $7,994,572.00 cost-plus-fixed-fee definitive contract awarded by the Defense Threat Reduction Agency (DTRA) to the Ministry of Defence (MOD), doing business as the Defence Science and Technology Laboratory (DSTL), a United Kingdom government entity. The contract is for the generation of a novel antibody-antibiotic conjugate as a combination therapy platform to treat melioidosis or plague. This contract is not set aside. DSTL has secured multiple high-value federal contracts from DTRA...

This federal contract award, valued at $5,379,526.00, was issued by the Defense Threat Reduction Agency (DTRA) to the Ministry of Defence (MOD), doing business as the Defence Science and Technology Laboratory (DSTL), a United Kingdom government entity. The award is for a base period and does not have a set-aside designation. DSTL has an Indefinite Delivery Vehicle (IDV) contract with the National Institute of Allergy and Infectious Diseases (NIAID) worth up to $146.3 million over seven years,...